/Home/USA/Life Sciences in USA - Nationwide/Greenberg Traurig, LLP
View profile of Greenberg Traurig, LLP
Department profile
Greenberg Traurig, LLP
Department profile | Greenberg Traurig, LLP
Life Sciences

About

Provided by Greenberg Traurig, LLP

Greenberg Traurig's Life Sciences & Medical Technology Group comprises attorneys with multidisciplinary and practical skills, aiding clients in diverse technologies and product solutions. Start-ups, large multinational public companies, research organizations, and not-for-profit care providers, as well as investors, venture capital funds, and public agencies, look to us to guide them from discovery through commercialization and product marketing. Our team is positioned to provide innovative and informed legal advice with the combined experience of the firm’s health care, intellectual property, governmental affairs, regulatory, corporate, real estate, litigation, products liability, and employment professionals. We handle transactional and litigation matters and representation before administrative and regulatory agencies, and frequently advise on FDA-related matters. Together, our attorneys and governmental professionals help our clients advance their products from the lab to the marketplace.

Chambers Review

Provided by Chambers

Life Sciences - USA - Nationwide

5
Band 5

What the Team is Known For

Greenberg Traurig is known for its comprehensive life sciences offering covering both litigation and commercial matters. The team regularly represents clients across the sector including drug and medical device manufacturers. The group is well poised to offer advice relating to patent infringement cases, patent prosecution, and IP portfolio management as well as strategic collaboration agreements, Hatch-Waxman disputes and IP licensing.

Notable practitioners

David Dykeman and Wayne Elowe are cochairs of the practice and key contacts.

Work Highlights

Provided by Greenberg Traurig, LLP

  • Greenberg Traurig represented Moderna in a suit brought by Promosome asserting that Moderna's COVID-19 vaccine products infringed a patent relating to a method of mutating mRNA sequences to improve protein expression efficacy.

Strengths

Provided by Chambers

"The Greenberg Traurig team provides excellent client service. They are highly skilled, very responsive and agile."

Life Sciences respondent
USA

"The GT team is super responsive and attuned to the company's needs."

Life Sciences respondent
USA